ICPT logo

ICPT Net Income

ICPT Annual Net Income

$221.82 M
+$313.24 M+342.62%

31 December 2022

ICPT Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Quarterly Net Income

-$2.79 M
+$3.07 M+52.41%

30 September 2023

ICPT Quarterly Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT TTM Net Income

-$61.61 M
-$270.24 M-129.53%

30 September 2023

ICPT TTM Net Income Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

ICPT Net Income Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+342.6%-101.0%-129.9%
3 y3 years+164.3%+95.8%+80.8%
5 y5 years+161.6%+95.7%+82.1%

ICPT Net Income High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall timeat high-101.0%-127.8%

Intercept Pharmaceuticals Net Income History

DateAnnualQuarterlyTTM
Sept 2023
-
-$2.79 M(-52.4%)
-$61.61 M(-129.5%)
June 2023
-
-$5.86 M(-81.8%)
$208.63 M(+0.8%)
Mar 2023
-
-$32.13 M(+54.3%)
$206.97 M(-6.7%)
Dec 2022
$221.82 M(-342.6%)
-$20.82 M(-107.8%)
$221.82 M(+7.5%)
Sept 2022
-
$267.45 M(-3652.8%)
$206.36 M(-418.8%)
June 2022
-
-$7.53 M(-56.4%)
-$64.72 M(-5.2%)
Mar 2022
-
-$17.28 M(-52.4%)
-$68.29 M(-25.3%)
Dec 2021
-$91.43 M(-66.7%)
-$36.28 M(+898.9%)
-$91.43 M(-14.8%)
Sept 2021
-
-$3.63 M(-67.3%)
-$107.29 M(-36.9%)
June 2021
-
-$11.09 M(-72.6%)
-$170.13 M(-23.5%)
Mar 2021
-
-$40.42 M(-22.5%)
-$222.32 M(-19.1%)
Dec 2020
-$274.88 M(-20.3%)
-$52.15 M(-21.5%)
-$274.88 M(-14.3%)
Sept 2020
-
-$66.47 M(+5.0%)
-$320.89 M(-5.4%)
June 2020
-
-$63.28 M(-31.9%)
-$339.25 M(-2.3%)
Mar 2020
-
-$92.98 M(-5.3%)
-$347.39 M(+0.8%)
Dec 2019
-$344.68 M(+11.5%)
-$98.16 M(+15.7%)
-$344.68 M(+3.0%)
Sept 2019
-
-$84.83 M(+18.8%)
-$334.53 M(+6.5%)
June 2019
-
-$71.42 M(-20.9%)
-$314.15 M(-1.2%)
Mar 2019
-
-$90.27 M(+2.6%)
-$317.92 M(+2.8%)
Dec 2018
-$309.24 M(-14.2%)
-$88.00 M(+36.5%)
-$309.24 M(-7.0%)
Sept 2018
-
-$64.45 M(-14.3%)
-$332.51 M(-2.4%)
June 2018
-
-$75.19 M(-7.8%)
-$340.66 M(-3.2%)
Mar 2018
-
-$81.59 M(-26.7%)
-$352.03 M(-2.3%)
Dec 2017
-$360.37 M
-$111.27 M(+53.3%)
-$360.37 M(-2.4%)
Sept 2017
-
-$72.60 M(-16.1%)
-$369.14 M(-4.2%)
DateAnnualQuarterlyTTM
June 2017
-
-$86.56 M(-3.7%)
-$385.35 M(+2.5%)
Mar 2017
-
-$89.93 M(-25.1%)
-$376.08 M(-8.9%)
Dec 2016
-$412.83 M(+82.3%)
-$120.04 M(+35.2%)
-$412.83 M(+8.3%)
Sept 2016
-
-$88.81 M(+14.9%)
-$381.04 M(+11.1%)
June 2016
-
-$77.30 M(-39.0%)
-$343.12 M(+9.4%)
Mar 2016
-
-$126.67 M(+43.5%)
-$313.72 M(+38.5%)
Dec 2015
-$226.43 M(-20.1%)
-$88.25 M(+73.4%)
-$226.43 M(+30.9%)
Sept 2015
-
-$50.90 M(+6.3%)
-$173.00 M(+9.5%)
June 2015
-
-$47.89 M(+21.6%)
-$157.95 M(+106.2%)
Mar 2015
-
-$39.39 M(+13.1%)
-$76.58 M(-73.0%)
Dec 2014
-$283.23 M(+317.8%)
-$34.82 M(-2.8%)
-$283.23 M(+8.6%)
Sept 2014
-
-$35.84 M(-207.1%)
-$260.77 M(+1.6%)
June 2014
-
$33.47 M(-113.6%)
-$256.66 M(-15.5%)
Mar 2014
-
-$246.03 M(+1889.3%)
-$303.61 M(+347.9%)
Dec 2013
-$67.79 M(+55.3%)
-$12.37 M(-61.0%)
-$67.79 M(-21.3%)
Sept 2013
-
-$31.74 M(+135.5%)
-$86.11 M(+44.6%)
June 2013
-
-$13.48 M(+32.0%)
-$59.56 M(+16.4%)
Mar 2013
-
-$10.21 M(-66.7%)
-$51.17 M(+17.3%)
Dec 2012
-$43.64 M(+242.6%)
-$30.69 M(+491.7%)
-$43.64 M(+162.9%)
Sept 2012
-
-$5.19 M(+2.0%)
-$16.60 M(+16.5%)
June 2012
-
-$5.09 M(+89.8%)
-$14.25 M(+55.5%)
Mar 2012
-
-$2.68 M(-26.5%)
-$9.17 M(+41.3%)
Dec 2011
-$12.74 M(-15.6%)
-$3.65 M(+28.3%)
-$6.49 M(+128.3%)
Sept 2011
-
-$2.84 M
-$2.84 M
Dec 2010
-$15.09 M
-
-

FAQ

  • What is Intercept Pharmaceuticals annual net profit?
  • What is the all time high annual net income for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals annual net income year-on-year change?
  • What is Intercept Pharmaceuticals quarterly net profit?
  • What is the all time high quarterly net income for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals quarterly net income year-on-year change?
  • What is Intercept Pharmaceuticals TTM net profit?
  • What is the all time high TTM net income for Intercept Pharmaceuticals?
  • What is Intercept Pharmaceuticals TTM net income year-on-year change?

What is Intercept Pharmaceuticals annual net profit?

The current annual net income of ICPT is $221.82 M

What is the all time high annual net income for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high annual net profit is $221.82 M

What is Intercept Pharmaceuticals annual net income year-on-year change?

Over the past year, ICPT annual net profit has changed by +$313.24 M (+342.62%)

What is Intercept Pharmaceuticals quarterly net profit?

The current quarterly net income of ICPT is -$2.79 M

What is the all time high quarterly net income for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high quarterly net profit is $267.45 M

What is Intercept Pharmaceuticals quarterly net income year-on-year change?

Over the past year, ICPT quarterly net profit has changed by -$270.24 M (-101.04%)

What is Intercept Pharmaceuticals TTM net profit?

The current TTM net income of ICPT is -$61.61 M

What is the all time high TTM net income for Intercept Pharmaceuticals?

Intercept Pharmaceuticals all-time high TTM net profit is $221.82 M

What is Intercept Pharmaceuticals TTM net income year-on-year change?

Over the past year, ICPT TTM net profit has changed by -$267.97 M (-129.86%)